GlassScriptPhysician profile
Benjamin M Suh
NPI 1336554476
$1,397.10
in general payments reported to CMS, 2019-2025
13 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $97.70 · 2021: $255 · 2022: $231 · 2023: $272 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $542.55 | 2020-2025 | Grafix Pl, Acticoat 4" X 4", Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Stryker Corporation | $188.87 | 2022 | |
| Merck Sharp & Dohme LLC | $163.29 | 2019 | |
| Paragon 28, INC. | $154.82 | 2025 | Smart28 |
| Horizon Therapeutics Plc | $73.23 | 2019 | |
| Grt US Holding, INC. | $51.05 | 2020-2021 | |
| Melinta Therapeutics, LLC | $50.12 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $43.35 | 2019 | |
| Integra Lifesciences Corporation | $32.67 | 2025 | Tcc-Ez |
| Ermi LLC | $30.18 | 2021 | |
| Abbvie INC. | $28.45 | 2021 | |
| Abbott Laboratories | $22.36 | 2021 | |
| Dynasplint Systems INC. | $16.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Suh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.